Wuhan HealthCare Biotechnology Co.
Latest round
- Series C
Last raised
- Jul 2021
Total raised
- $4.5M
Investors
- 7
About Wuhan HealthCare Biotechnology Co.
, Ltd. is a medical service provider that provides clinical diagnosis of major diseases for clinical hospitals and third-party independent clinical testing institutions and guide clinical drug molecular diagnostic products and clinical molecular diagnostic programs. The company cooperated with pathology Branch of China Medical Equipment Association to set up a training base, and also cooperated with Peking Union Medical College Hospital, Peking University Cancer Hospital and other hospitals., Ltd., Ltd. The company mainly provides molecular diagnostic equipment and testing services, including rapid fluorescence in situ hybridization probes, pharmacogenomics detection reagents and fluorescence in situ hybridization equipment. Its self-developed FastProbe® fluorescence in situ hybridization probe preparation technology shortens the detection time of fluorescence in situ hybridization from 3 days to several hours, and has higher sensitivity, specificity and bright signal-to-noise ratio. The company's products are mainly used in major diseases such as cardiovascular, cerebrovascular, tumor, cancer, etc. The company is promoting the implementation of two automated testing equipment in the field of solid tumors and hematological tumors, and it is expected to be put on the market in the second half of 2021 at the earliest.
Who invested in Wuhan HealthCare Biotechnology Co.
7 investors across 4 rounds
See all investors in Wuhan HealthCare Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Wuhan HealthCare Biotechnology Co.
Who invested in Wuhan HealthCare Biotechnology Co.?
Wuhan HealthCare Biotechnology Co. has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Wuhan HealthCare Biotechnology Co. raised?
Wuhan HealthCare Biotechnology Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Wuhan HealthCare Biotechnology Co. last raise money?
Wuhan HealthCare Biotechnology Co.'s most recent round on record is a Series C, in Jul 2021.
What does Wuhan HealthCare Biotechnology Co. do?
Wuhan HealthCare Biotechnology Co. is a biotechnology company.
Where is Wuhan HealthCare Biotechnology Co. headquartered?
Wuhan HealthCare Biotechnology Co. is headquartered in Wuhan, China.
Which VCs invest in companies like Wuhan HealthCare Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Wuhan HealthCare Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Wuhan HealthCare Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.